4163.TWO Intai Technology
- Market cap
- TWD 6.06B
- P/E
- 19.4x
- P/B
- 2.31x
- ROE
- 10.7%
- Dividend yield
- 2.81%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 4163.TWO undervalued?
Graham number4163.TWO trades 41.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Intai Technology fundamental analysis
No fundamental analysis for Intai Technology yet.
Intai Technology stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Intai Technology
INTAI Technology Corporation produces and sells medical devices and precision fasteners. The company offers medical products for minimally invasive surgery, cardiovascular, diagnostic devices, laparotomy, energy medical devices, and robotic assisted surgery applications. It also provides various medical implantable devices for orthopedic trauma, spine, dental, hip and knee, surgical instruments, and craniomaxillofacial trauma applications. It also provides RF microwave produ…
Full company profileIntai Technology financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Intai Technology annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.05B | 1.81B | 1.91B | 2.33B | 1.96B | 1.97B | 2.41B | 2.44B | 2.38B | 2.41B | 2.61B |
| Gross Profit | 869M | 676M | 755M | 991M | 826M | 790M | 973M | 1.03B | 983M | 1.07B | 1.10B |
| Operating Income | 400M | 257M | 312M | 447M | 305M | 282M | 535M | 448M | 242M | 284M | 320M |
| EBITDA | - | 285M | 459M | 573M | 409M | 396M | 656M | 586M | 510M | 498M | 558M |
| Net Income | 352M | 152M | 292M | 364M | 247M | 228M | 422M | 341M | 260M | 250M | 289M |
| EPS | - | 3.11 | 5.99 | 7.48 | 5.11 | 4.73 | 8.74 | 7.05 | 5.23 | 5.02 | 5.70 |
| Balance Sheet | |||||||||||
| Total Assets | 2.83B | 2.81B | 3.05B | 3.04B | 3.46B | 3.75B | 4.56B | 4.79B | 4.67B | 4.85B | 4.76B |
| Total Liabilities | 1.29B | 1.38B | 1.42B | 1.19B | 1.60B | 1.82B | 2.31B | 2.25B | 2.00B | 2.08B | 2.00B |
| Shareholders' Equity | 1.54B | 1.43B | 1.63B | 1.84B | 1.86B | 1.93B | 2.25B | 2.47B | 2.61B | 2.71B | 2.70B |
| Cash & Short-term Investments | 1.06B | 956M | 957M | 975K | 1.05B | 873M | 1.16B | 1.32B | 877M | 991M | 814M |
| Total Debt | - | - | - | - | 1.03B | 1.23B | 1.51B | 1.62B | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 491M | 215M | 360M | 494M | 307M | 61.0M | 426M | 579M | 275M | 459M | 509M |
| Capital Expenditure | 59.3M | 64.0M | 189M | 119M | 255M | 362M | 408M | 388M | 210M | 186M | 55.9M |
| Free Cash Flow | - | 146M | 169M | 372M | 52.0M | -301M | 18.7M | 191M | 64.7M | 273M | 453M |
| Ratios | |||||||||||
| ROE | 22.9% | 10.6% | 17.9% | 19.8% | 13.3% | 11.9% | 18.7% | 13.8% | 10.0% | 9.2% | 10.7% |
| ROA | 12.5% | 5.4% | 9.6% | 12.0% | 7.1% | 6.1% | 9.3% | 7.1% | 5.6% | 5.1% | 6.1% |
| Net Profit Margin | 17.1% | 8.4% | 15.3% | 15.6% | 12.6% | 11.6% | 17.5% | 13.9% | 10.9% | 10.4% | 11.1% |
| Debt to Equity | - | - | - | - | 0.55x | 0.64x | 0.67x | 0.66x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Intai Technology dividends
- Dividend yield
- 2.81%
- Forward dividend
- 3.50 TWD
- Payout ratio
- 68.2%
- Ex-dividend date
- Mar 23, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 170M | 3.43 | 68.2% |
| 2024 | TWD 169M | 3.40 | 65.0% |
| 2023 | TWD 193M | 4.00 | 56.7% |
| 2022 | TWD 121M | 2.50 | 28.6% |
| 2021 | TWD 169M | 3.50 | 74.0% |
| 2020 | TWD 201M | 4.16 | 81.5% |
| 2019 | TWD 181M | 3.72 | 49.7% |
| 2018 | TWD 92.5M | 1.90 | 31.7% |
| 2017 | TWD 241M | 4.96 | 159.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1210000:1000000 on Aug 28, 2020.
Who owns Intai Technology
- Insiders 53.71%
- Institutions 1.15%
- Public & others 45.14%
- Shares outstanding 50.7M
- Free float 31.4M
Intai Technology company profile
- Company name
- Intai Technology
- Ticker
- 4163.TWO
- ISIN
- TW0004163001
- Exchange
- Taiwan OTC Exchange
- Sector
- Industrials
- Industry
- Machinery
- Fiscal year end
- December
- Address
- 9 Jingke Road, Taichung, Taiwan, 408
- Phone
- 886 4 2359 5336
- Website
- intai.com.tw
About Intai Technology
INTAI Technology Corporation produces and sells medical devices and precision fasteners. The company offers medical products for minimally invasive surgery, cardiovascular, diagnostic devices, laparotomy, energy medical devices, and robotic assisted surgery applications. It also provides various medical implantable devices for orthopedic trauma, spine, dental, hip and knee, surgical instruments, and craniomaxillofacial trauma applications. It also provides RF microwave products for production testing solution, ate and AI testing, military defense, emergency, and satellite data reception industries; and industrial application products. In addition, the company is involved in metal process, molding, secondary process, laser manufacturing, material application, and assembly. INTAI Technology Corporation was founded in 1988 and is based in Taichung, Taiwan.
Intai Technology management
7- Mr. Zhao Xun ZhongCTO, Head of the Incubation Business Unit & Chairman
- Mr. Jun-Nan LinGM & Director
- Ms. Ya Ling ChenHead of Finance & Accounting Manager
- Mr. Bao Zhang LinChief Strategy Officer & Director
- Mr. Qingfeng ChenDeputy General Manager
- Mr. Jin Xiang WangDeputy General Manager
- Mr. Meng Hui LinDeputy General Manager of the Industrial Applications Division